about
OTULIN restricts Met1-linked ubiquitination to control innate immune signalingUbiquitylation as a Rheostat for TCR Signaling: From Targeted Approaches Toward Global ProfilingTNF biology, pathogenic mechanisms and emerging therapeutic strategiesWhen ubiquitin meets NF-κB: a trove for anti-cancer drug developmentProtein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligasesRegulation of nuclear factor-κB in autoimmunityUbiquitin in the immune systemNF-κB in inflammation and renal diseasesLinear ubiquitination signals in adaptive immune responsesTNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagyRegulation of A20 and other OTU deubiquitinases by reversible oxidationStructural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like ProteaseTCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complexCYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune SignalingThe Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and AutoimmunityOTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3HTLV-1 Tax Functions as a Ubiquitin E3 Ligase for Direct IKK Activation via Synthesis of Mixed-Linkage Polyubiquitin ChainsParadoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancerTRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinomaIdentification of new IκBα complexes by an iterative experimental and mathematical modeling approach.NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases.Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6.USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responsesHSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination.Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-κappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cellsDeubiquitinating enzymes as promising drug targets for infectious diseases.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 inductionRING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling.Negative regulation of NF-κB signaling in T lymphocytes by the ubiquitin-specific protease USP34Multi-omic data integration links deleted in breast cancer 1 (DBC1) degradation to chromatin remodeling in inflammatory responseCYLD enhances severe listeriosis by impairing IL-6/STAT3-dependent fibrin productionThe IκB kinase complex in NF-κB regulation and beyond.Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity.CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.Loss of Trabid, a new negative regulator of the drosophila immune-deficiency pathway at the level of TAK1, reduces life span.Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasomeUbiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signalingCYLD-mediated signaling and diseases.RNF4 negatively regulates NF-κB signaling by down-regulating TAB2.
P2860
Q24296844-27A14705-971C-4D6D-895B-22D44CEBBD60Q26770849-9638C6AF-9E61-4AF7-9B58-38D7434CC7ABQ26776492-67FCEFC8-FD31-47F8-BF88-686939E209C4Q26827754-3415B0E1-10F9-4D5B-BC52-A19909E28085Q26852269-64F80F6A-F4EE-4739-A95F-E3BD0B2DB393Q26860148-43E1913E-785B-49EF-ACD2-10D2DECB0E08Q26998711-F75581E1-5462-4AE3-BB29-64EEAAE79730Q27021276-37D64558-AB81-4584-8577-BDEC3625CD5DQ27027872-2CC556EB-4521-4FDF-A1D5-AEF65D01583EQ27311305-ADB7E767-9257-4415-B8FA-129EBC98E695Q27676707-E4060EB3-2110-46B1-BB31-DD8F160EB51BQ27683898-93AE97A1-30F1-44A1-BA08-91401009FD0AQ28085394-FF7A6BD2-9B2F-40DA-864D-B74AF59B7A6FQ28117541-8D20DF32-7376-4AF5-8953-AD7F61C55B8FQ28118489-A212EC60-07C3-4C4C-93A3-622E7FAE8F8AQ28513798-CD7EE233-4C96-42EA-AAF7-BBEB0D732AF8Q28551396-5C7CD64C-6520-40A1-85E5-1D660644F664Q28588141-ED6C906D-D40E-41DC-9EB3-CD4CA96A6A56Q30491128-B99E788B-FA7A-4CC7-80C1-6CE68A507BCFQ31154854-EEC4FEF5-027E-4C28-A76E-F942BA71DC79Q33576114-447AA415-B117-4D82-ADCA-79B29819F2D7Q33590960-26BCFE6C-921A-4C10-9559-CAAA6EDC0C5AQ33655162-E735ADCD-B553-4022-81BA-0DD090322CACQ33720245-6D8B6C23-C2B7-464E-9368-A0B1FB9A7698Q33800452-3D4D87EE-475A-46CF-9EAB-58863A1C2FB7Q33836097-D808FD65-CB78-4E9A-8487-D57082475CFFQ33889168-B7C410C7-6297-4A06-98AD-B0E74C785EDBQ34011478-F662FF96-4B8D-435F-B05D-B14FBACAA828Q34545358-A60FB1EC-ED73-45B7-B6C7-6D76439B5AFFQ34670791-884530EE-B7DA-480E-BB12-B573262F0F45Q34703669-3DA8784F-2B8C-4D14-A453-9BCBE78C4396Q34795465-052A64FA-36E4-43B0-8E67-702415814A4CQ35001723-1369671E-FC89-4D32-A7FB-BEFDD7E7E7D2Q35005858-B277AD2F-26FD-4C8F-9507-85C6108592B9Q35009699-B3C8D052-4A53-4935-9E0A-F5309ECC066AQ35105686-400E8969-4F87-499E-9148-3EB4D0678181Q35207348-554E334E-9CD6-4AE1-BD29-0262E61CDC1AQ35451225-12D50F8C-9C39-4B5F-9F71-4BAE3DE0E259Q35565726-386CAF2B-0645-43D8-9ECD-D83A5D7925F7Q35753160-AF7EF6A0-CF72-45A8-B2D7-2D47B4728B8C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Regulation of NF-κB by deubiquitinases.
@en
Regulation of NF-κB by deubiquitinases.
@nl
type
label
Regulation of NF-κB by deubiquitinases.
@en
Regulation of NF-κB by deubiquitinases.
@nl
prefLabel
Regulation of NF-κB by deubiquitinases.
@en
Regulation of NF-κB by deubiquitinases.
@nl
P2860
P1476
Regulation of NF-κB by deubiquitinases.
@en
P2093
Edward W Harhaj
Vishva M Dixit
P2860
P304
P356
10.1111/J.1600-065X.2012.01100.X
P577
2012-03-01T00:00:00Z